---
title: Buy Memantine 10mg Pills Online
description: Memantine 10mg pills help manage moderate to severe Alzheimer's dementia symptoms in adults. Shop securely from our trusted online pharmacy offering verified quality and discreet delivery.
type: product
language: en 
url: https://liabilis.com/order-memantine-online-en.html
availability: in_stock
shipping:
  - type: Standard Airmail
    price: 10.00
    currency: USD
    area: Worldwide
    time: 14-21 days
  - type: Tracked Express
    price: 30.00
    currency: USD
    area: Worldwide
    tracking: true
    time: 5-9 days
price_min: 89.99
price_max: 377.99
currency: USD
offers:
  - name: 10mg x 30 pills
    price: 89.99
  - name: 10mg x 60 pills
    price: 149.99
  - name: 10mg x 90 pills
    price: 206.99
  - name: 10mg x 120 pills
    price: 263.99
  - name: 10mg x 180 pills
    price: 377.99
---

# Buy Memantine 10mg Pills Online

Memantine is an NMDA receptor antagonist used to treat moderate to severe dementia of the Alzheimer's type. It works by regulating glutamate activity in the brain to help improve memory, attention, and the ability to perform daily tasks in adults. This medication is suitable for patients needing support with cognitive decline. Available in 10mg pills at our online pharmacy.

## Pricing and Options

| Dosage | Pack Size | Price (USD) | Price Per Pill | Status |
| :--- | :--- | :--- | :--- | :--- |
| **10mg** | 30 pills | **$89.99** | $3.00 | In Stock |
| **10mg** | 60 pills | **$149.99** | $2.50 | In Stock |
| **10mg** | 90 pills | **$206.99** | $2.30 | In Stock |
| **10mg** | 120 pills | **$263.99** | $2.20 | In Stock |
| **10mg** | 180 pills | **$377.99** | $2.10 | In Stock |


[Buy Now](https://liabilis.com/order-memantine-online-en.html)

## Introduction 
Memantine is a prescription medication used primarily to treat moderate-to-severe Alzheimer’s disease. Its active ingredient is also named Memantine, and it is supplied as a 10 mg oral pill. Memantine belongs to the class of NMDA-receptor antagonists, a group of drugs that modulate glutamate-mediated neuronal activity. While its main indication is Alzheimer’s disease, clinicians sometimes consider it for other forms of dementia or neurological injury under careful supervision.

## Quick Reference Facts 

**Active Ingredient** 
: Memantine 

**Form** 
: pill 10 mg 

**Primary and Off-Label Uses** 
: • Moderate-to-severe Alzheimer’s disease - approved indication 
: • Vascular dementia (off-label) 
: • Traumatic brain injury (off-label) 
: • Parkinson’s disease-related dementia (off-label) 

## What is Memantine? 
Memantine is the generic version of medications containing the active compound Memantine. It is classified as an **N-methyl-D-aspartate (NMDA) receptor antagonist**. The most widely recognized brand equivalents are **Namenda** (single-agent memantine) and **Namzaric** (a fixed-dose combination of memantine and donepezil). The drug was originally developed by Targacept and later marketed by Forest Laboratories under the Namenda name. Generic memantine offers the same therapeutic effect as these brand products, meeting the same stringent bioequivalence standards required by regulatory agencies. 

## How Memantine Works 
Memantine binds to the NMDA receptor channel at a site distinct from the glutamate binding site. It is a **low-affinity, uncompetitive antagonist**, meaning it blocks the receptor only when it is excessively activated by high levels of glutamate. In Alzheimer’s disease, over-activation of NMDA receptors can lead to calcium overload and neuronal excitotoxicity, contributing to cognitive decline. By moderating this pathway, memantine helps preserve neuronal function without completely shutting down normal glutamatergic transmission. 

Pharmacokinetically, memantine is rapidly absorbed after oral administration, reaching peak plasma concentrations within 3-8 hours. Approximately 100 % of the dose is excreted unchanged by the kidneys; thus, renal function strongly influences drug clearance. The half-life averages 60-80 hours, supporting once-daily dosing. Memantine does not undergo extensive hepatic metabolism, reducing the likelihood of drug-enzyme-mediated interactions.

## Conditions Treated with Memantine 

- **Moderate-to-severe Alzheimer’s disease** 
 Memantine improves cognition, behavior, and daily functioning by reducing excitotoxic neuronal damage. Clinical trials have demonstrated modest but statistically significant benefits on standardized cognitive scales (e.g., ADAS-Cog, MMSE). 

- **Parkinson’s disease-related dementia (off-label, occasionally prescribed)** 
 Some neurologists use memantine to address cognitive fluctuations and visual hallucinations associated with Parkinsonian dementia, leveraging its NMDA-blocking properties. 

- **Vascular dementia (off-label)** 
 Evidence suggests that memantine may help mitigate cognitive decline caused by chronic cerebral ischemia, though data remain less robust than for Alzheimer’s disease. 

- **Traumatic brain injury (off-label)** 
 In cases of moderate to severe head injury, memantine’s neuroprotective action is explored to limit secondary injury processes. 

## Is Memantine the Right Medication for You? 
Memantine is most appropriate for adults diagnosed with moderate to severe Alzheimer’s disease who have not responded adequately to cholinesterase inhibitors alone. It is often added when patients exhibit progressive cognitive loss despite stable doses of donepezil, rivastigmine, or galantamine. 

Suitable candidates typically have preserved renal function (creatinine clearance > 30 mL/min) because the drug is primarily renally cleared. Patients with known hypersensitivity to memantine or any tablet excipients should avoid it. 

Contraindications include severe renal impairment requiring dialysis and any condition where NMDA antagonism might worsen symptoms (e.g., uncontrolled seizure disorders). Caution is advised for individuals on concurrent NMDA-targeting agents (such as amantadine) due to potential additive effects. 

Ultimately, the decision rests with a qualified healthcare provider who can assess disease stage, comorbidities, and potential drug interactions.

## Buying Memantine from [our online pharmacy](https://liabilis.com/order-memantine-online-en.html) 

### Why Choose Our Service? 
Accessing memantine can be challenging when insurance formularies restrict coverage or when local pharmacies experience shortages. Our platform offers a reliable, cost-effective route to obtain the medication without compromising quality. 

### Quality & Safety Assurance 
We partner with licensed international pharmacies to ensure quality and authenticity. Every batch of memantine is sourced from manufacturers that meet stringent Good Manufacturing Practice (GMP) standards, and all shipments undergo independent verification. 

### Pricing & Access 
Because memantine is available as a generic, we can provide it at prices close to the manufacturer’s baseline cost, often substantially lower than branded alternatives such as Namenda. This makes long-term therapy more affordable for patients managing chronic cognitive disorders. 

### Discreet Delivery 
Your order will be packaged in unmarked, tamper-evident containers and dispatched with express options that typically arrive within seven business days, or via standard airmail in approximately three weeks. Privacy and speed are integral to our service model. 

## Use: Dosing, Missed Dose, Overdose 

- **Standard dosing** - The usual regimen begins with 5 mg once daily for one week, then increases to 10 mg daily. Most patients reach a maintenance dose of 20 mg per day (10 mg twice daily). For the 10 mg tablet, clinicians may prescribe it once daily or split the dose as directed. 

- **Missed dose** - If a dose is forgotten and more than 12 hours have elapsed, skip the missed tablet and resume the regular schedule. Do not double-dose to compensate. 

- **Overdose** - Signs of memristic overdose include dizziness, severe nausea, vomiting, agitation, or seizures. If an overdose is suspected, seek emergency medical attention promptly; supportive care and monitoring are the primary treatments. 

- **Administration tips** - Memantine may be taken with or without food. Alcohol should be limited, as both substances can increase the risk of dizziness and impaired coordination. Patients should refrain from operating heavy machinery until they know how the medication affects them. 

## Safety Information 

### ⚠️ Who Should Not Take Memantine 
- Known hypersensitivity to memantine or any tablet ingredient. 
- Severe renal impairment (creatinine clearance < 30 mL/min) without dose adjustment. 
- Patients receiving other NMDA antagonists without professional guidance. 

### Common Side Effects 
- Dizziness or light-headedness (≈ 10 %). 
- Headache (≈ 8 %). 
- Constipation (≈ 5 %). 
- Mild nausea or abdominal discomfort. 
These effects are usually transient and lessen after dose titration. 

### Serious Side Effects (Seek Immediate Medical Help) 
- Severe allergic reaction: rash, itching, swelling, or difficulty breathing. 
- Hallucinations, severe agitation, or pronounced confusion. 
- Seizures (rare but reported). 
- Sudden increase in blood pressure or arrhythmia. 
If any of these occur, contact emergency services without delay. 

### Drug & Food Interactions 
- **Antacids or acid-reducing agents** (e.g., omeprazole, ranitidine) may decrease memantine absorption; spacing doses by at least two hours is advised. 
- **Amantadine or other NMDA antagonists** can potentiate memantine’s effects, increasing the risk of neuropsychiatric symptoms. 
- **Renal-clearing drugs** (e.g., cimetidine, trimethoprim) may raise memantine concentrations; monitor renal function closely. 
- **Alcohol** enhances central nervous system depression, potentially worsening dizziness or confusion. 

## Off-Label and Investigational Uses of Memantine 
Clinical studies have explored memantine for **traumatic brain injury**, suggesting modest improvements in cognitive recovery when administered within the acute phase. In **vascular dementia**, limited trials indicate possible stabilization of cognition, though evidence is not definitive. Some research investigates memantine as an adjunct in **schizophrenia** to address negative symptoms, but results remain inconsistent. These off-label applications are not approved by regulatory agencies; they should only be pursued under specialist supervision with informed consent. 

## Storage & Handling 
- Keep tablets at room temperature (20-25 °C / 68-77 °F). 
- Protect from excess moisture, light, and heat. 
- Store out of reach of children and pets. 
- Do not use tablets after the printed expiration date. 
- Dispose of unused medication through a pharmacy-take-back program or according to local hazardous-waste guidelines. 

## Frequently Asked Questions 

**Practical Use & Lifestyle** 

- **Can I travel internationally with memantine?** 
 Yes, but carry the medication in its original container with a copy of the prescription. Some countries require a doctor’s note, so verify local import regulations before departure. 

- **Should I take memantine at a specific time of day?** 
 Consistency is key. Most clinicians recommend taking it once daily in the morning or dividing the dose into morning and evening doses to maintain steady plasma levels. 

**Product & Formulation Details** 

- **What does a memantine tablet look like?** 
 Generic 10 mg tablets are typically white, round, and film-coated, but appearance can vary by manufacturer. 

- **Are there any inactive ingredients I should be aware of?** 
 Common excipients include microcrystalline cellulose, lactose, and magnesium stearate. Patients with severe lactose intolerance should consult their pharmacist. 

**Regulatory & Safety Nuances** 

- **Will memantine appear on a standard drug test for athletes?** 
 Memantine is not listed on the World Anti-Doping Agency (WADA) prohibited substances list and is generally not screened for in routine occupational drug tests. 

- **Is memantine safe for people over 85 years old?** 
 Elderly patients can use memantine, but dose adjustments may be needed for reduced renal function. Close monitoring for dizziness and falls is advisable. 

**Scientific & Clinical Curiosity** 

- **What was the pivotal trial that led to memantine’s approval?** 
 The FDA approved memantine based on two Phase III studies (the MEM-MD-02 and MEM-MD-12 trials) that demonstrated significant benefits in cognition and daily living activities for patients with moderate-to-severe Alzheimer’s disease. 

- **How does memantine differ from older NMDA antagonists like amantadine?** 
 Memantine has a lower affinity and faster off-rate at the NMDA channel, allowing normal neurotransmission while preventing pathological over-activation. Amantadine, by contrast, has broader dopaminergic activity and a higher risk of psychosis at therapeutic doses. 

## Glossary 

**NMDA Receptor Antagonist** 
: A drug that blocks the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors, reducing excitatory neurotransmission that can lead to neuronal injury. 

**Bioequivalence** 
: Demonstration that a generic drug delivers the same amount of active ingredient into the bloodstream as the reference brand product, within an accepted variance range. 

**Excitotoxicity** 
: Cell death caused by excessive stimulation of neurons, often due to high levels of glutamate, leading to calcium overload and oxidative damage. 

## Disclaimer 

The information provided about **Memantine** is intended for general educational purposes and does not substitute personalized medical advice. Treatment choices, including any off-label applications, must be made under the direction of a qualified healthcare professional. Readers are assumed to be competent adults capable of making informed health decisions. [our online pharmacy](https://liabilis.com/order-memantine-online-en.html) supplies Memantine for individuals who encounter limited availability through conventional pharmacies, face insurance barriers, or seek cost-effective generic options. Always discuss any medication changes with your physician before initiating, adjusting, or discontinuing therapy.